Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...

The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Here’s what that means If the FDA panel’s recommendation is endorsed by the CDC, only a single composition of vaccine – in this case, the updated bivalent ... Pfizer's says its COVID-19 ...

British drugmaker GSK told Manhattan prosecutors that a former employee told colleagues Pfizer held back positive results until after the 2020 election. But the former employee, who worked at both ...

[What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers in the United States set an audacious goal in January last year to develop a coronavirus vaccine within 12 to ...

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make their COVID-19 vaccine. Siding with Moderna, an American pharmaceutical ...

and has invalidated two of the patents at the heart of an ongoing lawsuit between Pfizer and Moderna, the two companies who famously brought mRNA vaccines for Covid-19 to market months after the ...

DUESSELDORF, Germany, March 5 (Reuters) - A German court on Wednesday ruled that Pfizer (PFE.N), opens new tab and its partner BioNTech (22UAy.DE), opens new tab violated a COVID-19 vaccine patent ...